This website uses cookies to collect usage information in order to offer a better browsing experience. By browsing this site or by clicking on the "ACCEPT COOKIES" button you accept our Cookie Policy.

The FIGS Co-Founders Are Worth Nearly $700 Million After an Impressive IPO

Co-CEOs Heather Hasson and Trina Spear own a combined $700 million in shares. According to FIGS, proceeds from the IPO will go towards company expansion.

After changing the healthcare apparel industry as we know it, fashionable scrubs maker FIGS went public Thursday on the New York Stock Exchange. The company’s IPO generated even more buzz earlier this week as Robinhood allowed users to buy the stock before the public debut.

FIGS priced its IPO at $22 per share, well above the expected range, bringing its valuation well into unicorn status, up to $4.4 billion. The company’s co-founders, meanwhile, saw their fortunes climb as a result. 

According to our data based on FIGS’ S-1 filing, co-founder and co-CEO Trina Spear owns shares worth $318.9 million, while her fellow co-founder and co-CEO Heather Hasson owns around $350 million in shares, making their combined holdings worth nearly $700 million. Proceeds from the IPO will go towards company expansion, fueled by the growth of the healthcare industry itself.

Spear and Hasson aren’t the only ones whose fortunes have exploded as a result of the IPO. Movie producer Thomas Tull, the largest investor in FIGS, owns shares worth $478 million.

Founded in 2013, FIGS sought to disrupt the $10 billion medical scrubs market by making versions that were well-fitting and comfortable. Spear, a former Wall Street investment banker, and Hasson, an entrepreneur in the fashion industry, linked up to found FIGS after Hasson discovered that most medical professionals were dissatisfied with traditional scrubs. Hasson didn’t come into the medical world by accident — after studying pre-med in college, she moved into fashion before realizing that a friend who was a nurse needed alterations on her scrubs. After doing alterations on more nurses’ scrubs, Hasson realized she had a business idea on her hands.

The pandemic proved to be a boon for the company: Last year, revenue more than doubled to $263 million, while the company made nearly $50 million in profit. FIGS was barely breaking even before that point, despite growing popularity among healthcare professionals. Unlike most apparel industries, healthcare apparel is comparatively fad and recession-resistant, likely boosting confidence among investors.

About the Data:

Thinknum tracks companies using the information they post online, jobs, social and web traffic, product sales, and app ratings, and creates data sets that measure factors like hiring, revenue, and foot traffic. Data sets may not be fully comprehensive (they only account for what is available on the web), but they can be used to gauge performance factors like staffing and sales.

Originally Posted on May 27, 2021 – The FIGS Co-Founders Are Worth Nearly $700 Million After an Impressive IPO

Disclosure: Interactive Brokers

Information posted on IBKR Traders’ Insight that is provided by third-parties and not by Interactive Brokers does NOT constitute a recommendation by Interactive Brokers that you should contract for the services of that third party. Third-party participants who contribute to IBKR Traders’ Insight are independent of Interactive Brokers and Interactive Brokers does not make any representations or warranties concerning the services offered, their past or future performance, or the accuracy of the information provided by the third party. Past performance is no guarantee of future results.

This material is from The Business of Business - Thinknum Media and is being posted with permission from The Business of Business - Thinknum Media. The views expressed in this material are solely those of the author and/or The Business of Business - Thinknum Media and IBKR is not endorsing or recommending any investment or trading discussed in the material. This material is not and should not be construed as an offer to sell or the solicitation of an offer to buy any security. To the extent that this material discusses general market activity, industry or sector trends or other broad based economic or political conditions, it should not be construed as research or investment advice. To the extent that it includes references to specific securities, commodities, currencies, or other instruments, those references do not constitute a recommendation to buy, sell or hold such security. This material does not and is not intended to take into account the particular financial conditions, investment objectives or requirements of individual customers. Before acting on this material, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

In accordance with EU regulation: The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.

Any trading symbols displayed are for illustrative purposes only and are not intended to portray recommendations.

trading top